Dysmagnesemia in Covid-19 cohort patients: prevalence and associated factors

Fiche du document

Date

2020

Type de document
Périmètre
Langue
Identifiant
Collection

Cairn.info

Organisation

Cairn

Licence

Cairn




Citer ce document

Didier Quilliot et al., « Dysmagnesemia in Covid-19 cohort patients: prevalence and associated factors », Magnesium Research, ID : 10670/1.55nflc


Métriques


Partage / Export

Résumé 0

Hypomagnesemia and hypermagnesemia could have serious implications and possibly lead to progress from a mild form to a severe outcome of Covid-19. Susceptibility of subjects with low magnesium status to develop and enhance this infection is possible. There is little data on the magnesium status of patients with Covid-19 with different degrees of severity. This study was conducted to evaluate prevalence of dysmagnesemia in a prospective Covid-19 cohort study according to the severity of the clinical manifestations and to identify factors associated.Serum magnesium was measured in 300 of 549 patients admitted to the hospital due to severe Covid-19. According to the WHO guidelines, patients were classified as moderate, severe, or critical. 48% patients had a magnesemia below 0.75 mmol/L (defined as magnesium deficiency) including 13% with a marked hypomagnesemia (

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en